{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:17:48Z","timestamp":1788214668909,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"36","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers, with over 83% of patients presenting metastases to vital organs such as the liver, lungs, and peritoneum. Although glycosylation has been established as a critical factor in PDAC development, little is known about the molecular underpinnings of organ-specific metastasis. In this study, we investigated the role of glycosyltransferases (GTs) in mediating PDAC metastatic organotropism. Through an unbiased transcriptomic screen, we identified distinct GT expression patterns in liver- and lung-tropic PDAC cells. Notably, GCNT3 and B3GNT3 were selectively upregulated in liver and lung-tropic cells, respectively. These mutually exclusive expression patterns were validated in human metastatic PDAC specimens, where GCNT3 was enriched in liver metastatic lesions and B3GNT3 in lung metastases. Proteomic profiling revealed that differential expression of these GTs is associated with epithelial-mesenchymal transition and glycoproteome remodeling in metastatic cells. Functional studies using in vitro assays, ex vivo organotypic cultures, and in vivo metastasis models demonstrated that loss of GCNT3 or B3GNT3 impairs the proliferation and survival of PDAC cells in their respective metastatic organ environments. Together, these findings uncover a glycosylation-based mechanism that facilitates organ-specific survival of metastatic PDAC cells and highlight glycosyltransferases as potential therapeutic targets for disrupting metastatic adaptation.<\/jats:p>","DOI":"10.1038\/s41388-026-03896-5","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:32:56Z","timestamp":1785418376000},"page":"3858-3873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis"],"prefix":"10.1038","volume":"45","author":[{"given":"Venkatesh","family":"Varadharaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedeta","family":"Krishna Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8962-2487","authenticated-orcid":false,"given":"Palanisamy","family":"Nallasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annant Bir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirtana","family":"Arikath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyatt","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-8546","authenticated-orcid":false,"given":"Sanchita","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelanjana","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1795-3598","authenticated-orcid":false,"given":"Zahraa Wajih","family":"Alsafwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poompozhil","family":"Mathivanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanakumar","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Mallya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Bommideni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-7381","authenticated-orcid":false,"given":"Jesse L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Talmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Grandgenett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-8888","authenticated-orcid":false,"given":"Michael A.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"DiMaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Grem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-9317","authenticated-orcid":false,"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-193X","authenticated-orcid":false,"given":"Moorthy P.","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"3896_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3896_CR2","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open. 2021;4:e214708.","journal-title":"JAMA Netw Open"},{"key":"3896_CR3","doi-asserted-by":"crossref","unstructured":"Collaborators GBDPC. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934\u201347.","DOI":"10.1016\/S2468-1253(19)30347-4"},{"key":"3896_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet"},{"key":"3896_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","volume":"9","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A, et al. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Target Ther. 2024;9:270.","journal-title":"Signal Transduct Target Ther"},{"key":"3896_CR6","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379:2395\u2013406.","journal-title":"N Engl J Med"},{"key":"3896_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3892\/ol.2024.14503","volume":"28","author":"O Mayuko","year":"2024","unstructured":"Mayuko O, Tsunenari T, Einama T, Ichio K, Konno F, Kobayashi K, et al. Pancreatic cancer with liver metastasis maintaining complete response with gemcitabine monotherapy: a case report. Oncol Lett. 2024;28:370.","journal-title":"Oncol Lett"},{"key":"3896_CR8","volume":"2022","author":"Q Li","year":"2022","unstructured":"Li Q, Bai L, Xing J, Liu X, Liu D, Hu X. Risk assessment of liver metastasis in pancreatic cancer patients using multiple models based on machine learning: a large population-based study. Dis Markers. 2022;2022:1586074.","journal-title":"Dis Markers"},{"key":"3896_CR9","doi-asserted-by":"publisher","first-page":"45649","DOI":"10.18632\/oncotarget.9861","volume":"7","author":"C Decoster","year":"2016","unstructured":"Decoster C, Gilabert M, Autret A, Turrini O, Oziel-Taieb S, Poizat F, et al. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study. Oncotarget. 2016;7:45649\u201355.","journal-title":"Oncotarget"},{"key":"3896_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2025.1535212","volume":"12","author":"P Zhao","year":"2025","unstructured":"Zhao P, Jiang Q, Xue K, Liu X, Tian B. The role of pulmonary metastasectomy in patients suffering pancreatic ductal adenocarcinoma with lung metastases: a systematic review and meta-analysis. Front Surg. 2025;12:1535212.","journal-title":"Front Surg"},{"key":"3896_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/PAS.0b013e318240c1c0","volume":"36","author":"D Chatterjee","year":"2012","unstructured":"Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Varadhachary GR, et al. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol. 2012;36:552\u20139.","journal-title":"Am J Surg Pathol"},{"key":"3896_CR12","doi-asserted-by":"publisher","first-page":"E4066","DOI":"10.1073\/pnas.1406619111","volume":"111","author":"P Radhakrishnan","year":"2014","unstructured":"Radhakrishnan P, Dabelsteen S, Madsen FB, Francavilla C, Kopp KL, Steentoft C, et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc Natl Acad Sci USA. 2014;111:E4066\u20134075.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3896_CR13","doi-asserted-by":"crossref","unstructured":"Gupta R, Leon F, Rauth S, Batra SK, Ponnusamy MP. A systematic review on the implications of O-linked glycan branching and truncating enzymes on cancer progression and metastasis. Cells. 2020;9:446.","DOI":"10.3390\/cells9020446"},{"key":"3896_CR14","doi-asserted-by":"crossref","unstructured":"Lumibao JC, Tremblay JR, Hsu J, Engle DD. Altered glycosylation in pancreatic cancer and beyond. J Exp Med. 2022;219:e20211505.","DOI":"10.1084\/jem.20211505"},{"key":"3896_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s42003-021-02934-0","volume":"5","author":"E Rodriguez","year":"2022","unstructured":"Rodriguez E, Boelaars K, Brown K, Madunic K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41.","journal-title":"Commun Biol"},{"key":"3896_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41388-021-02047-2","volume":"41","author":"F Leon","year":"2022","unstructured":"Leon F, Seshacharyulu P, Nimmakayala RK, Chugh S, Karmakar S, Nallasamy P, et al. Reduction in O-glycome induces differentially glycosylated CD44 to promote stemness and metastasis in pancreatic cancer. Oncogene. 2022;41:57\u201371.","journal-title":"Oncogene"},{"key":"3896_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fonc.2020.00732","volume":"10","author":"T Zhang","year":"2020","unstructured":"Zhang T, van Die I, Tefsen B, van Vliet SJ, Laan LC, Zhang J, et al. Differential O- and glycosphingolipid glycosylation in human pancreatic adenocarcinoma cells with opposite morphology and metastatic behavior. Front Oncol. 2020;10:732.","journal-title":"Front Oncol"},{"key":"3896_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2021.01.015","volume":"503","author":"S Sagar","year":"2021","unstructured":"Sagar S, Leiphrakpam PD, Thomas D, McAndrews KL, Caffrey TC, Swanson BJ, et al. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans. Cancer Lett. 2021;503:91\u2013102.","journal-title":"Cancer Lett"},{"key":"3896_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0386-1","volume":"14","author":"BT Hofmann","year":"2015","unstructured":"Hofmann BT, Schluter L, Lange P, Mercanoglu B, Ewald F, Folster A, et al. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Mol Cancer. 2015;14:109.","journal-title":"Mol Cancer"},{"key":"3896_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.tcb.2024.09.006","volume":"35","author":"V Varadharaj","year":"2024","unstructured":"Varadharaj V, Petersen W, Batra SK, Ponnusamy MP. Sugar symphony: glycosylation in cancer metabolism and stemness. Trends Cell Biol. 2024;35:412\u2013425.","journal-title":"Trends Cell Biol"},{"key":"3896_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1158\/1541-7786.MCR-21-0888","volume":"20","author":"S Marimuthu","year":"2022","unstructured":"Marimuthu S, Lakshmanan I, Muniyan S, Gautam SK, Nimmakayala RK, Rauth S, et al. MUC16 promotes liver metastasis of pancreatic ductal adenocarcinoma by upregulating NRP2-associated cell adhesion. Mol Cancer Res. 2022;20:1208\u201321.","journal-title":"Mol Cancer Res"},{"key":"3896_CR22","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41416-020-0772-3","volume":"122","author":"R Gupta","year":"2020","unstructured":"Gupta R, Leon F, Thompson CM, Nimmakayala R, Karmakar S, Nallasamy P, et al. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Br J Cancer. 2020;122:1661\u201372.","journal-title":"Br J Cancer"},{"key":"3896_CR23","doi-asserted-by":"crossref","unstructured":"Marimuthu S, Batra SK, Ponnusamy MP. Pan-cancer analysis of altered glycosyltransferases confers poor clinical outcomes. Clin Transl Discov. 2022;2:e100.","DOI":"10.1002\/ctd2.100"},{"key":"3896_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1023\/A:1011900818419","volume":"18","author":"N Kitamura","year":"2000","unstructured":"Kitamura N, Iwamura T, Taniguchi S, Yamanari H, Kawano MA, Hollingsworth K, et al. High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice. Clin Exp Metastasis. 2000;18:561\u201371.","journal-title":"Clin Exp Metastasis"},{"key":"3896_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/sj.neo.7900005","volume":"1","author":"CJ Bruns","year":"1999","unstructured":"Bruns CJ, Harbison MT, Kuniyasu H, Eue I, Fidler IJ. In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia. 1999;1:50\u201362.","journal-title":"Neoplasia"},{"key":"3896_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10555-021-10015-1","volume":"41","author":"WE Bindeman","year":"2022","unstructured":"Bindeman WE, Fingleton B. Glycosylation as a regulator of site-specific metastasis. Cancer Metastasis Rev. 2022;41:107\u201329.","journal-title":"Cancer Metastasis Rev"},{"key":"3896_CR27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1158\/2159-8290.CD-13-0287","volume":"4","author":"N Murugaesu","year":"2014","unstructured":"Murugaesu N, Iravani M, van Weverwijk A, Ivetic A, Johnson DA, Antonopoulos A, et al. An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor. Cancer Discov. 2014;4:304\u201317.","journal-title":"Cancer Discov"},{"key":"3896_CR28","doi-asserted-by":"crossref","unstructured":"Zhang Y, Sun L, Lei C, Li W, Han J, Zhang J. et al. A sweet warning: mucin-type O-glycans in cancer. Cells. 2022;11:3666.","DOI":"10.3390\/cells11223666"},{"key":"3896_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"Mereiter S, Balmana M, Campos D, Gomes J, Reis CA. Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell. 2019;36:6\u201316.","journal-title":"Cancer Cell"},{"key":"3896_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"3896_CR31","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1158\/0008-5472.CAN-15-2820","volume":"76","author":"CV Rao","year":"2016","unstructured":"Rao CV, Janakiram NB, Madka V, Kumar G, Scott EJ, Pathuri G, et al. Small-molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer. Cancer Res. 2016;76:1965\u201374.","journal-title":"Cancer Res"},{"key":"3896_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335.","journal-title":"Nature"},{"key":"3896_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.","journal-title":"Signal Transduct Target Ther"},{"key":"3896_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02182-w","volume":"24","author":"R Lusby","year":"2025","unstructured":"Lusby R, Demirdizen E, Inayatullah M, Kundu P, Maiques O, Zhang Z, et al. Pan-cancer drivers of metastasis. Mol Cancer. 2025;24:2.","journal-title":"Mol Cancer"},{"key":"3896_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44341-024-00007-x","volume":"2","author":"A Agrawal","year":"2025","unstructured":"Agrawal A, Javanmardi Y, Watson SA, Serwinski B, Djordjevic B, Li W, et al. Mechanical signatures in cancer metastasis. NPJ Biol Phys Mech. 2025;2:3.","journal-title":"NPJ Biol Phys Mech"},{"key":"3896_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112646","volume":"42","author":"A Alard","year":"2023","unstructured":"Alard A, Katsara O, Rios-Fuller T, Parra C, Ozerdem U, Ernlund A, et al. Breast cancer cell mesenchymal transition and metastasis directed by DAP5\/eIF3d-mediated selective mRNA translation. Cell Rep. 2023;42:112646.","journal-title":"Cell Rep"},{"key":"3896_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2017.03.002","volume":"44","author":"L Oliveira-Ferrer","year":"2017","unstructured":"Oliveira-Ferrer L, Legler K, Milde-Langosch K. Role of protein glycosylation in cancer metastasis. Semin Cancer Biol. 2017;44:141\u201352.","journal-title":"Semin Cancer Biol"},{"key":"3896_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51831-7","volume":"15","author":"CH Hung","year":"2024","unstructured":"Hung CH, Wu SY, Yao CD, Yeh HH, Lin CC, Chu CY, et al. Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer. Nat Commun. 2024;15:7885.","journal-title":"Nat Commun"},{"key":"3896_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fonc.2016.00033","volume":"6","author":"X Li","year":"2016","unstructured":"Li X, Wang X, Tan Z, Chen S, Guan F. Role of glycans in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol. 2016;6:33.","journal-title":"Front Oncol"},{"key":"3896_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/15680096113136660100","volume":"13","author":"MP Ponnusamy","year":"2013","unstructured":"Ponnusamy MP, Seshacharyulu P, Lakshmanan I, Vaz AP, Chugh S, Batra SK. Emerging role of mucins in epithelial to mesenchymal transition. Curr Cancer Drug Targets. 2013;13:945\u201356.","journal-title":"Curr Cancer Drug Targets"},{"key":"3896_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1442888","volume":"15","author":"C Biray Avci","year":"2024","unstructured":"Biray Avci C, Goker Bagca B, Nikanfar M, Takanlou LS, Takanlou MS, Nourazarian A. Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications. Front Pharm. 2024;15:1442888.","journal-title":"Front Pharm"},{"key":"3896_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","volume":"178","author":"M Ligorio","year":"2019","unstructured":"Ligorio M, Sil S, Malagon-Lopez J, Nieman LT, Misale S, Di Pilato M, et al. Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer. Cell. 2019;178:160\u2013175.e127.","journal-title":"Cell"},{"key":"3896_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15:73\u201386.","journal-title":"Nat Rev Immunol"},{"key":"3896_CR44","doi-asserted-by":"crossref","unstructured":"Augustin HG, Koh GY. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science. 2017;357:eaal2379.","DOI":"10.1126\/science.aal2379"},{"key":"3896_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"3896_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature10694","volume":"481","author":"I Malanchi","year":"2011","unstructured":"Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481:85\u201389.","journal-title":"Nature"},{"key":"3896_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540\u201355.","journal-title":"Nat Rev Cancer"},{"key":"3896_CR48","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1074\/mcp.R112.026989","volume":"12","author":"JW Dennis","year":"2013","unstructured":"Dennis JW, Brewer CF. Density-dependent lectin-glycan interactions as a paradigm for conditional regulation by posttranslational modifications. Mol Cell Proteom. 2013;12:913\u201320.","journal-title":"Mol Cell Proteom"},{"key":"3896_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u201326.","journal-title":"Trends Cell Biol"},{"key":"3896_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18:128\u201334.","journal-title":"Nat Rev Cancer"},{"key":"3896_CR51","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/2159-8290.CD-13-0760","volume":"5","author":"NE Reticker-Flynn","year":"2015","unstructured":"Reticker-Flynn NE, Bhatia SN. Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche. Cancer Discov. 2015;5:168\u201381.","journal-title":"Cancer Discov"},{"key":"3896_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216796120","volume":"120","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Wang H, Chai S, Xu L, Lin B, Yi W, et al. O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation. Proc Natl Acad Sci USA. 2023;120:e2216796120.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03896-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:02:52Z","timestamp":1788213772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03896-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":52,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2026,9,22]]}},"alternative-id":["3896"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03896-5","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SKB is one of the cofounders of Sanguine Diagnostics and Therapeutics, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Human primary tumor, liver metastasis, and lung metastasis specimens from decedents previously diagnosed with pancreatic cancer were obtained from the University of Nebraska Medical Center Tissue Bank through the Rapid Autopsy Program (RAP) for Pancreas in compliance with Institutional Review Board (IRB) protocol 091\u201301. Informed consent was obtained from all participants or their legally authorized representatives in accordance with the approved IRB protocol. Animal experiments were conducted under protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Nebraska Medical Center, Omaha, Nebraska. All animal studies were performed in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}